Lloyd George W.
SEC CIK 1814899 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RPRX | Royalty Pharma plc | EVP, GC, Investments | 0 | — | $57.55M | 22 | 2021-07-06 | 2025-12-17 |
Most active insiders at RPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coyne Terrance P. | EVP, CFO | — | $38.96M |
| 2 | Hite Christopher | EVP, Vice COB | — | $27.36M |
| 3 | Lloyd George W. | EVP, CLO, Investments | — | $13.81M |
| 4 | Urist Marshall | EVP, Research, Investments | — | $12.07M |
| 5 | Norden Gregory | Dir | — | $161.4K |
| 6 | Engelbert Catherine M. | Dir | — | — |
| 7 | Ho Carole | Dir | — | — |
| 8 | Coric Vlad | Dir | — | — |
| 9 | Bassler Bonnie L | Dir | — | — |
| 10 | Legorreta Pablo G. | CEO, COB, Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-12-19 | 2025-12-17+ | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | S - Sale | $38.55 | -110.0K | 0 | -100% | -$4.24M |
| I | 2025-12-05 | 2025-12-03 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | S - Sale | $39.77 | -110.0K | 110.0K | -50% | -$4.37M |
| MI | 2025-11-21 | 2025-11-19 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | S - Sale | $38.34 | -132.4K | 0 | -100% | -$5.08M |
| M | 2025-11-21 | 2025-11-19 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | S - Sale | $38.35 | -3,000 | 230 | -93% | -$115.0K |
| I | 2025-11-07 | 2025-11-05 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | A - Grant | $0.00 | +6,168 | 58.5K | +12% | $0 |
| DI | 2025-08-08 | 2025-08-06 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | A - Grant | $0.00 | +3,696 | 52.3K | +8% | $0 |
| I | 2025-05-09 | 2025-05-08 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | A - Grant | $0.00 | +48.6K | 48.6K | New | $0 |
| DMI | 2023-11-14 | 2023-11-13 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | C - Cnv Deriv | $0.00 | +150.0K | 80.0K | New | $0 |
| MI | 2023-06-06 | 2023-06-02+ | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | S - Sale | $33.71 | -192.2K | 30.0K | -86% | -$6.48M |
| MI | 2023-03-30 | 2023-03-28+ | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | S - Sale | $37.06 | -112.8K | 225.0K | -33% | -$4.18M |
| I | 2023-02-27 | 2023-02-23 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | S - Sale | $37.27 | -25.0K | 325.0K | -7% | -$931.8K |
| MI | 2022-11-22 | 2022-11-21+ | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | S - Sale | $43.14 | -40.0K | 351.9K | -10% | -$1.73M |
| DMI | 2022-11-14 | 2022-11-10 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, CLO, Investments | S - Sale | $43.85 | -50.0K | 355.0K | -12% | -$2.19M |
| MI | 2022-08-11 | 2022-08-09+ | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, GC, Investments | S - Sale | $43.92 | -20.9K | 201.1K | -9% | -$916.0K |
| I | 2022-08-01 | 2022-07-28 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, GC, Investments | S - Sale | $43.97 | -4,046 | 222.0K | -2% | -$177.9K |
| MI | 2022-07-27 | 2022-07-25+ | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, GC, Investments | S - Sale | $43.25 | -75.1K | 405.0K | -16% | -$3.25M |
| MI | 2022-05-31 | 2022-05-26+ | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, GC, Investments | S - Sale | $40.29 | -100.0K | 430.0K | -19% | -$4.03M |
| I | 2022-05-25 | 2022-05-23 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, GC, Investments | S - Sale | $40.27 | -100.0K | 530.0K | -16% | -$4.03M |
| DMI | 2021-11-18 | 2021-11-16+ | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, GC, Investments | S - Sale | $42.39 | -250.0K | 495.9K | -34% | -$10.60M |
| MI | 2021-07-27 | 2021-07-26 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, GC, Investments | S - Sale | $39.78 | -13.4K | 595.9K | -2% | -$531.5K |
| MI | 2021-07-14 | 2021-07-12+ | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, GC, Investments | S - Sale | $42.01 | -23.1K | 600.8K | -4% | -$972.5K |
| MI | 2021-07-08 | 2021-07-06+ | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, GC, Investments | S - Sale | $42.20 | -88.5K | 849.7K | -9% | -$3.73M |
Purchase Sale Sale after option exercise All abbreviations